相关实验视频
Updated: May 24, 2025

08:51
Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
4.1K
脑小脑认知情感综合征在患有10型脊脑小脑动症的患者中
Angel Omar Romero-Molina1,2, Gabriel Ramirez-Garcia2, Amanda Chirino-Perez2
1Instituto de Neuroetologia, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
PloS one
|March 3, 2025
概括
脊髓脑动症10型 (SCA10) 患者表现为大脑脑认知情感综合征 (CCAS). 该CCAS尺度 (CCAS-S) 有效地识别了CCAS,其表现受到年龄和抑郁症的影响.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 临床神经学 临床神经学
背景情况:
- 脊髓小脑动症10型 (SCA10) 是一种自体主导的大脑动症.
- SCA10呈现出,无氧和与大脑认知情感综合征 (CCAS) 相关的认知障碍.
- 小脑认知情感综合征 (CCAS-S) 尺度有助于在各种小脑疾病中识别CCAS.
研究的目的:
- 在SCA10患者中使用CCAS-S.评估CCAS.
- 为了比较CCAS-S与蒙特利尔认知评估 (MoCA) 的疗效.
- 调查人口和临床因素对CCAS-S性能的影响.
主要方法:
- 评估了15名SCA10患者和15名匹配的对照.
- 这些评估包括CCAS-S,MoCA,Scale for the Assessment and Rating of Ataxia (SARA) 和CES-D. 这些评估包括CCAS-S,MoCA,Scale for the Assessment and Rating of Ataxia (SARA) 和CES-D.
- 使用ROC曲线分析来确定诊断准确度和比较分数.
主要成果:
- 在SCA10中,CCAS-S对SCA10的认知障碍表现出良好的诊断准确性 (AUC0.83).
- 虽然MoCA没有显示出显著的AUC差异,但CCAS-S具有更大的效果大小.
- SCA10患者的认知表现较差;年龄和抑郁症状显著影响了CCAS-S得分.
结论:
- SCA10患者表现出CCAS,由CCAS-S证实.
- 在SCA10中,CCAS-S在检测CCAS方面是有效的,与MoCA相似.
- 年龄和抑郁症状是影响SCA10中CCAS-S结果的关键因素.
相关概念视频
Major Somatic Sensory Pathways
851
Sensory impulses related to touch, pressure, vibration, and proprioception from various body parts, such as the limbs, trunk, neck, and posterior head, travel to the cerebral cortex through the posterior column-medial lemniscus pathway. The pathway’s name derives from the two white-matter tracts that convey the impulses: the spinal cord's posterior column and the brainstem's medial lemniscus. First-order sensory neurons extend their axons into the spinal cord, forming the...
851
Negative and Cognitive Symptoms of Schizophrenia
39
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
39
Alzheimer's Disease: Overview
418
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
418
Role of Cerebellum and Prefrontal Cortex in Memory
322
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
322
Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419

